Drugs that should be avoided - Official List

Search for drug names and trade names in various countries [exclusive section]  
» View country-specific list of these drugs' trade names [exclusive section] »

[ Drug names in red are of high risk to all deficiency types. ]

NameMolecular Formula Risk Level
(note)
For WhomNotes
Data pager
Page size:
select
 81 items in 6 pages
76   Low All
77   Low Medit., Asian
1 Acetanilide (acetanilid) C8 H9 N O High Medit., Asian
2 Acetylphenylhydrazine (2-Phynylacetohydrazide) C8 H10 N2 O High All Note
3 Aldesulfone sodium (sulfoxone) C14 H14 N2 Na2 O6 S3 High All
4 Aminophenazone (aminopyrine) C13 H17 N3 O Low All
5 Antazoline (antistine) C17 H19 N3 Low All
78 Arginine (acido 2(S)-ammino-5-guanidilpentanoico) C6H14N4O2 Low All
6 Arsine As-H3 High All Note
7 Ascorbic Acid C6 H8 O6 Low All
8 Beta-Naphthol (2-Naphthol) C10 H8 O High All
81 Brinzolamide   High All Note
9 Chloramphenicol C11 H12 C12 N2 O5 High Medit., Asian
10 Chloroquine C18 H26 Cl N3 High Medit., Asian Note
11 Ciprofloxacin C17 H18 F N3 O3 High Medit., Asian Note

Miscellaneous elements besides drugs that should be avoided:

Fava Beans
(Some, but only some, prefer also to avoid red wine, henna (see below), all legumes, blueberries [also yogurts containing these], soya products, tonic water: whether you should avoid any of these would depend on your enzyme deficit level and mutation.)

Black Henna (Indigofera tinctoria), Red Egyptian Henna (Lawsonia inermis) and other related dyes, used for both tattoos and hair dyes. Ann Trop in Pediatr 16: 287, 1996 and Kök AN, Ertekin MV, Ertekin V, Avci B. in Int J Clin Pract 58: 530, 2004) have shown that henna might trigger in G6PD deficient persons hemolytic crisis or at least an excessive hemolysis.
In vitro experiments suggest that the substance responsible for such hemolysis is 2-hydroxy-1,4-naphthoquinone (or lawsone: see Pediatrcis 97:707,1996).
[Information generously offered to the Association by Prof. Lucio Luzzatto, Scientific Director at the Istituto Toscano Tumori, Firenze, Italy; Consultant at the Department of Human Genetics and Division of Hematologic Oncology at the Department of Medicine Memorial Hospital for Cancer and Allied Diseases at the Memorial Sloan Kettering Cancer Center, New York]